Trial intelligence / Profile preview

Stillen vs Mucosta in Acute or Chronic Gastritis

NCT01817556Phase 4Completed

Sponsor
Dong-A ST
Start
Oct 2012
Primary completion
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Stillen in acute gastritis and chronic gastritis (2 arms), sponsored by Dong-A ST. Primary endpoint: Improvement rates of erosive gastritis at 4 weeks. Started Oct 2012; status: completed.

02

Drugs

Stillen
03

Conditions

acute gastritischronic gastritis

Beyond the preview

Go deeper on NCT01817556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01817556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call